APO Research
Talk to an analyst

APO RESEARCH · REPORT

Inhaler Devices for Respiratory Medicines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Inhaler Devices for Respiratory Medicines Market Outlook and Growth Opportunities 2026

29 December 2025196 pages

Choose your research edition.

Industry ResearchInhaler Devices for Respiratory Medicines Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Inhaler Devices for Respiratory Medicines Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Inhaler Devices for Respiratory Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Inhaler Devices for Respiratory Medicines Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Inhaler Devices for Respiratory Medicines Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Inhaler Devices for Respiratory Medicines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Inhaler Devices for Respiratory Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Inhaler Devices for Respiratory Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Inhaler Devices for Respiratory Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Inhaler Devices for Respiratory Medicines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Inhaler Devices for Respiratory Medicines market include Novartis, Viatris, Mylan, AstraZeneca, Vectura, Teva Pharmaceutical Industries, PARI International, OMRON and Monaghan Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Inhaler Devices for Respiratory Medicines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Inhaler Devices for Respiratory Medicines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Inhaler Devices for Respiratory Medicines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Inhaler Devices for Respiratory Medicines market size, projected growth trends, production technologies, key applications, and end-use industries.

Inhaler Devices for Respiratory Medicines Segment by Company

Novartis

Viatris

Mylan

AstraZeneca

Vectura

Teva Pharmaceutical Industries

PARI International

OMRON

Monaghan Medical

Koninklijke Philips

H&T Presspart

GlaxoSmithKline (GSK)

Chiesi Farmaceutici

Boehringer Ingelheim

AptarGroup

Inhaler Devices for Respiratory Medicines Segment by Type

Metered- dose Inhalers

Dry-powder Inhalers

Nebulizers

Inhaler Devices for Respiratory Medicines Segment by Application

Chronic Obstructive Pulmonary Disease (COPD)

Cystic Fibrosis (CF)

Idiopathic Pulmonary Fibrosis (IPF)

Asthma

Others

Inhaler Devices for Respiratory Medicines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Inhaler Devices for Respiratory Medicines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Inhaler Devices for Respiratory Medicines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Inhaler Devices for Respiratory Medicines significant trends, drivers, influence factors in global and regions.

6. To analyze Inhaler Devices for Respiratory Medicines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Inhaler Devices for Respiratory Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Inhaler Devices for Respiratory Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Inhaler Devices for Respiratory Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Inhaler Devices for Respiratory Medicines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Inhaler Devices for Respiratory Medicines industry.

Chapter 3: Detailed analysis of Inhaler Devices for Respiratory Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Inhaler Devices for Respiratory Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Inhaler Devices for Respiratory Medicines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Inhaler Devices for Respiratory Medicines Industry Trends Table 2. Inhaler Devices for Respiratory Medicines Industry Drivers Table 3. Inhaler Devices for Respiratory Medicines Industry Opportunities and Challenges Table 4. Inhaler Devices for Respiratory Medicines Industry Restraints Table 5. Global Inhaler Devices for Respiratory Medicines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Inhaler Devices for Respiratory Medicines Revenue Share by Company (2021-2026) Table 7. Global Inhaler Devices for Respiratory Medicines Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Inhaler Devices for Respiratory Medicines Sales Volume Share by Company (2021-2026) Table 9. Global Inhaler Devices for Respiratory Medicines Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Inhaler Devices for Respiratory Medicines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Inhaler Devices for Respiratory Medicines Key Company Manufacturing Base & Headquarters Table 12. Global Inhaler Devices for Respiratory Medicines Company, Product Type & Application Table 13. Global Inhaler Devices for Respiratory Medicines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Inhaler Devices for Respiratory Medicines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Metered- dose Inhalers Table 18. Significant Companies of Dry-powder Inhalers Table 19. Significant Companies of Nebulizers Table 20. Global Inhaler Devices for Respiratory Medicines Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Inhaler Devices for Respiratory Medicines Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Inhaler Devices for Respiratory Medicines Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Inhaler Devices for Respiratory Medicines Sales Volume Share by Type (2021-2026) Table 24. Global Inhaler Devices for Respiratory Medicines Sales Volume Share by Type (2027-2032) Table 25. Global Inhaler Devices for Respiratory Medicines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Inhaler Devices for Respiratory Medicines Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Inhaler Devices for Respiratory Medicines Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Inhaler Devices for Respiratory Medicines Sales Value Share by Type (2021-2026) Table 29. Global Inhaler Devices for Respiratory Medicines Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Chronic Obstructive Pulmonary Disease (COPD) Table 31. Significant Companies of Cystic Fibrosis (CF) Table 32. Significant Companies of Idiopathic Pulmonary Fibrosis (IPF) Table 33. Significant Companies of Asthma Table 34. Significant Companies of Others Table 35. Global Inhaler Devices for Respiratory Medicines Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Inhaler Devices for Respiratory Medicines Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Inhaler Devices for Respiratory Medicines Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Inhaler Devices for Respiratory Medicines Sales Volume Share by Application (2021-2026) Table 39. Global Inhaler Devices for Respiratory Medicines Sales Volume Share by Application (2027-2032) Table 40. Global Inhaler Devices for Respiratory Medicines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Inhaler Devices for Respiratory Medicines Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Inhaler Devices for Respiratory Medicines Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Inhaler Devices for Respiratory Medicines Sales Value Share by Application (2021-2026) Table 44. Global Inhaler Devices for Respiratory Medicines Sales Value Share by Application (2027-2032) Table 45. Global Inhaler Devices for Respiratory Medicines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Inhaler Devices for Respiratory Medicines Sales by Region (2021-2026) & (K Units) Table 47. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Region (2021-2026) Table 48. Global Inhaler Devices for Respiratory Medicines Sales by Region (2027-2032) & (K Units) Table 49. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Region (2027-2032) Table 50. Global Inhaler Devices for Respiratory Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Inhaler Devices for Respiratory Medicines Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Inhaler Devices for Respiratory Medicines Sales Value Share by Region (2021-2026) Table 53. Global Inhaler Devices for Respiratory Medicines Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Inhaler Devices for Respiratory Medicines Sales Value Share by Region (2027-2032) Table 55. Global Inhaler Devices for Respiratory Medicines Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Inhaler Devices for Respiratory Medicines Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Inhaler Devices for Respiratory Medicines Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Inhaler Devices for Respiratory Medicines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Inhaler Devices for Respiratory Medicines Sales by Country (2021-2026) & (K Units) Table 60. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2021-2026) Table 61. Global Inhaler Devices for Respiratory Medicines Sales by Country (2027-2032) & (K Units) Table 62. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Country (2027-2032) Table 63. Global Inhaler Devices for Respiratory Medicines Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Inhaler Devices for Respiratory Medicines Sales Value Market Share by Country (2021-2026) Table 65. Global Inhaler Devices for Respiratory Medicines Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Inhaler Devices for Respiratory Medicines Sales Value Market Share by Country (2027-2032) Table 67. Novartis Company Information Table 68. Novartis Business Overview Table 69. Novartis Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Novartis Inhaler Devices for Respiratory Medicines Product Portfolio Table 71. Novartis Recent Development Table 72. Viatris Company Information Table 73. Viatris Business Overview Table 74. Viatris Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Viatris Inhaler Devices for Respiratory Medicines Product Portfolio Table 76. Viatris Recent Development Table 77. Mylan Company Information Table 78. Mylan Business Overview Table 79. Mylan Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Mylan Inhaler Devices for Respiratory Medicines Product Portfolio Table 81. Mylan Recent Development Table 82. AstraZeneca Company Information Table 83. AstraZeneca Business Overview Table 84. AstraZeneca Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. AstraZeneca Inhaler Devices for Respiratory Medicines Product Portfolio Table 86. AstraZeneca Recent Development Table 87. Vectura Company Information Table 88. Vectura Business Overview Table 89. Vectura Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Vectura Inhaler Devices for Respiratory Medicines Product Portfolio Table 91. Vectura Recent Development Table 92. Teva Pharmaceutical Industries Company Information Table 93. Teva Pharmaceutical Industries Business Overview Table 94. Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Product Portfolio Table 96. Teva Pharmaceutical Industries Recent Development Table 97. PARI International Company Information Table 98. PARI International Business Overview Table 99. PARI International Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. PARI International Inhaler Devices for Respiratory Medicines Product Portfolio Table 101. PARI International Recent Development Table 102. OMRON Company Information Table 103. OMRON Business Overview Table 104. OMRON Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. OMRON Inhaler Devices for Respiratory Medicines Product Portfolio Table 106. OMRON Recent Development Table 107. Monaghan Medical Company Information Table 108. Monaghan Medical Business Overview Table 109. Monaghan Medical Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Monaghan Medical Inhaler Devices for Respiratory Medicines Product Portfolio Table 111. Monaghan Medical Recent Development Table 112. Koninklijke Philips Company Information Table 113. Koninklijke Philips Business Overview Table 114. Koninklijke Philips Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Koninklijke Philips Inhaler Devices for Respiratory Medicines Product Portfolio Table 116. Koninklijke Philips Recent Development Table 117. H&T Presspart Company Information Table 118. H&T Presspart Business Overview Table 119. H&T Presspart Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. H&T Presspart Inhaler Devices for Respiratory Medicines Product Portfolio Table 121. H&T Presspart Recent Development Table 122. GlaxoSmithKline (GSK) Company Information Table 123. GlaxoSmithKline (GSK) Business Overview Table 124. GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Product Portfolio Table 126. GlaxoSmithKline (GSK) Recent Development Table 127. Chiesi Farmaceutici Company Information Table 128. Chiesi Farmaceutici Business Overview Table 129. Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Product Portfolio Table 131. Chiesi Farmaceutici Recent Development Table 132. Boehringer Ingelheim Company Information Table 133. Boehringer Ingelheim Business Overview Table 134. Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Product Portfolio Table 136. Boehringer Ingelheim Recent Development Table 137. AptarGroup Company Information Table 138. AptarGroup Business Overview Table 139. AptarGroup Inhaler Devices for Respiratory Medicines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. AptarGroup Inhaler Devices for Respiratory Medicines Product Portfolio Table 141. AptarGroup Recent Development Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Inhaler Devices for Respiratory Medicines Distributors List Table 145. Inhaler Devices for Respiratory Medicines Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Inhaler Devices for Respiratory Medicines Product Image Figure 2. Global Inhaler Devices for Respiratory Medicines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Inhaler Devices for Respiratory Medicines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Inhaler Devices for Respiratory Medicines Sales (2021-2032) & (K Units) Figure 5. Global Inhaler Devices for Respiratory Medicines Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Inhaler Devices for Respiratory Medicines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Metered- dose Inhalers Image Figure 10. Dry-powder Inhalers Image Figure 11. Nebulizers Image Figure 12. Global Inhaler Devices for Respiratory Medicines Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Inhaler Devices for Respiratory Medicines Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Inhaler Devices for Respiratory Medicines Sales Volume Share by Type (2021-2032) Figure 15. Global Inhaler Devices for Respiratory Medicines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Inhaler Devices for Respiratory Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Inhaler Devices for Respiratory Medicines Sales Value Share by Type (2021-2032) Figure 18. Chronic Obstructive Pulmonary Disease (COPD) Image Figure 19. Cystic Fibrosis (CF) Image Figure 20. Idiopathic Pulmonary Fibrosis (IPF) Image Figure 21. Asthma Image Figure 22. Others Image Figure 23. Global Inhaler Devices for Respiratory Medicines Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Inhaler Devices for Respiratory Medicines Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Inhaler Devices for Respiratory Medicines Sales Volume Share by Application (2021-2032) Figure 26. Global Inhaler Devices for Respiratory Medicines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Inhaler Devices for Respiratory Medicines Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Inhaler Devices for Respiratory Medicines Sales Value Share by Application (2021-2032) Figure 29. Global Inhaler Devices for Respiratory Medicines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Inhaler Devices for Respiratory Medicines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Inhaler Devices for Respiratory Medicines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Inhaler Devices for Respiratory Medicines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Inhaler Devices for Respiratory Medicines Sales Value (2021-2032) & (US$ Million) Figure 34. North America Inhaler Devices for Respiratory Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Inhaler Devices for Respiratory Medicines Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Inhaler Devices for Respiratory Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Inhaler Devices for Respiratory Medicines Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Inhaler Devices for Respiratory Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Inhaler Devices for Respiratory Medicines Sales Value (2021-2032) & (US$ Million) Figure 40. South America Inhaler Devices for Respiratory Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Inhaler Devices for Respiratory Medicines Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Inhaler Devices for Respiratory Medicines Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Inhaler Devices for Respiratory Medicines Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Inhaler Devices for Respiratory Medicines Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Metered- dose Inhalers
  • Dry-powder Inhalers
  • Nebulizers
Applications
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Cystic Fibrosis (CF)
  • Idiopathic Pulmonary Fibrosis (IPF)
  • Asthma
  • Others
Companies covered
  • Novartis
  • Viatris
  • Mylan
  • AstraZeneca
  • Vectura
  • Teva Pharmaceutical Industries
  • PARI International
  • OMRON
  • Monaghan Medical
  • Koninklijke Philips
  • H&T Presspart
  • GlaxoSmithKline (GSK)
  • Chiesi Farmaceutici
  • Boehringer Ingelheim
  • AptarGroup

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Inhaler Devices for Respiratory Medicines Sales Value (2021-2032)
  4. 1.2.2 Global Inhaler Devices for Respiratory Medicines Sales Volume (2021-2032)
  5. 1.2.3 Global Inhaler Devices for Respiratory Medicines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Inhaler Devices for Respiratory Medicines Market Dynamics
  1. 2.1 Inhaler Devices for Respiratory Medicines Industry Trends
  2. 2.2 Inhaler Devices for Respiratory Medicines Industry Drivers
  3. 2.3 Inhaler Devices for Respiratory Medicines Industry Opportunities and Challenges
  4. 2.4 Inhaler Devices for Respiratory Medicines Industry Restraints
3 Inhaler Devices for Respiratory Medicines Market by Company
  1. 3.1 Global Inhaler Devices for Respiratory Medicines Company Revenue Ranking in 2025
  2. 3.2 Global Inhaler Devices for Respiratory Medicines Revenue by Company (2021-2026)
  3. 3.3 Global Inhaler Devices for Respiratory Medicines Sales Volume by Company (2021-2026)
  4. 3.4 Global Inhaler Devices for Respiratory Medicines Average Price by Company (2021-2026)
  5. 3.5 Global Inhaler Devices for Respiratory Medicines Company Ranking (2024-2026)
  6. 3.6 Global Inhaler Devices for Respiratory Medicines Company Manufacturing Base and Headquarters
  7. 3.7 Global Inhaler Devices for Respiratory Medicines Company Product Type and Application
  8. 3.8 Global Inhaler Devices for Respiratory Medicines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Inhaler Devices for Respiratory Medicines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Inhaler Devices for Respiratory Medicines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Inhaler Devices for Respiratory Medicines Market by Type
  1. 4.1 Inhaler Devices for Respiratory Medicines Type Introduction
  2. 4.1.1 Metered- dose Inhalers
  3. 4.1.2 Dry-powder Inhalers
  4. 4.1.3 Nebulizers
  5. 4.2 Global Inhaler Devices for Respiratory Medicines Sales Volume by Type
  6. 4.2.1 Global Inhaler Devices for Respiratory Medicines Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Inhaler Devices for Respiratory Medicines Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Inhaler Devices for Respiratory Medicines Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Inhaler Devices for Respiratory Medicines Sales Value by Type
  10. 4.3.1 Global Inhaler Devices for Respiratory Medicines Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Inhaler Devices for Respiratory Medicines Sales Value by Type (2021-2032)
  12. 4.3.3 Global Inhaler Devices for Respiratory Medicines Sales Value Share by Type (2021-2032)
5 Inhaler Devices for Respiratory Medicines Market by Application
  1. 5.1 Inhaler Devices for Respiratory Medicines Application Introduction
  2. 5.1.1 Chronic Obstructive Pulmonary Disease (COPD)
  3. 5.1.2 Cystic Fibrosis (CF)
  4. 5.1.3 Idiopathic Pulmonary Fibrosis (IPF)
  5. 5.1.4 Asthma
  6. 5.1.5 Others
  7. 5.2 Global Inhaler Devices for Respiratory Medicines Sales Volume by Application
  8. 5.2.1 Global Inhaler Devices for Respiratory Medicines Sales Volume by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Inhaler Devices for Respiratory Medicines Sales Volume by Application (2021-2032)
  10. 5.2.3 Global Inhaler Devices for Respiratory Medicines Sales Volume Share by Application (2021-2032)
  11. 5.3 Global Inhaler Devices for Respiratory Medicines Sales Value by Application
  12. 5.3.1 Global Inhaler Devices for Respiratory Medicines Sales Value by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Inhaler Devices for Respiratory Medicines Sales Value by Application (2021-2032)
  14. 5.3.3 Global Inhaler Devices for Respiratory Medicines Sales Value Share by Application (2021-2032)
6 Inhaler Devices for Respiratory Medicines Regional Sales and Value Analysis
  1. 6.1 Global Inhaler Devices for Respiratory Medicines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Inhaler Devices for Respiratory Medicines Sales by Region (2021-2032)
  3. 6.2.1 Global Inhaler Devices for Respiratory Medicines Sales by Region: 2021-2026
  4. 6.2.2 Global Inhaler Devices for Respiratory Medicines Sales by Region (2027-2032)
  5. 6.3 Global Inhaler Devices for Respiratory Medicines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Inhaler Devices for Respiratory Medicines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Inhaler Devices for Respiratory Medicines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Inhaler Devices for Respiratory Medicines Sales Value by Region (2027-2032)
  9. 6.5 Global Inhaler Devices for Respiratory Medicines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Inhaler Devices for Respiratory Medicines Sales Value (2021-2032)
  12. 6.6.2 North America Inhaler Devices for Respiratory Medicines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Inhaler Devices for Respiratory Medicines Sales Value (2021-2032)
  15. 6.7.2 Europe Inhaler Devices for Respiratory Medicines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Inhaler Devices for Respiratory Medicines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Inhaler Devices for Respiratory Medicines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Inhaler Devices for Respiratory Medicines Sales Value (2021-2032)
  21. 6.9.2 South America Inhaler Devices for Respiratory Medicines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Inhaler Devices for Respiratory Medicines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Inhaler Devices for Respiratory Medicines Sales Value Share by Country, 2025 VS 2032
7 Inhaler Devices for Respiratory Medicines Country-level Sales and Value Analysis
  1. 7.1 Global Inhaler Devices for Respiratory Medicines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Inhaler Devices for Respiratory Medicines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Inhaler Devices for Respiratory Medicines Sales by Country (2021-2032)
  4. 7.3.1 Global Inhaler Devices for Respiratory Medicines Sales by Country (2021-2026)
  5. 7.3.2 Global Inhaler Devices for Respiratory Medicines Sales by Country (2027-2032)
  6. 7.4 Global Inhaler Devices for Respiratory Medicines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Inhaler Devices for Respiratory Medicines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Inhaler Devices for Respiratory Medicines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Inhaler Devices for Respiratory Medicines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Inhaler Devices for Respiratory Medicines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Inhaler Devices for Respiratory Medicines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Inhaler Devices for Respiratory Medicines Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Viatris
  8. 8.2.1 Viatris Company Information
  9. 8.2.2 Viatris Business Overview
  10. 8.2.3 Viatris Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Viatris Inhaler Devices for Respiratory Medicines Product Portfolio
  12. 8.2.5 Viatris Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Inhaler Devices for Respiratory Medicines Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca Inhaler Devices for Respiratory Medicines Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
  25. 8.5 Vectura
  26. 8.5.1 Vectura Company Information
  27. 8.5.2 Vectura Business Overview
  28. 8.5.3 Vectura Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Vectura Inhaler Devices for Respiratory Medicines Product Portfolio
  30. 8.5.5 Vectura Recent Developments
  31. 8.6 Teva Pharmaceutical Industries
  32. 8.6.1 Teva Pharmaceutical Industries Company Information
  33. 8.6.2 Teva Pharmaceutical Industries Business Overview
  34. 8.6.3 Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Teva Pharmaceutical Industries Inhaler Devices for Respiratory Medicines Product Portfolio
  36. 8.6.5 Teva Pharmaceutical Industries Recent Developments
  37. 8.7 PARI International
  38. 8.7.1 PARI International Company Information
  39. 8.7.2 PARI International Business Overview
  40. 8.7.3 PARI International Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 PARI International Inhaler Devices for Respiratory Medicines Product Portfolio
  42. 8.7.5 PARI International Recent Developments
  43. 8.8 OMRON
  44. 8.8.1 OMRON Company Information
  45. 8.8.2 OMRON Business Overview
  46. 8.8.3 OMRON Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 OMRON Inhaler Devices for Respiratory Medicines Product Portfolio
  48. 8.8.5 OMRON Recent Developments
  49. 8.9 Monaghan Medical
  50. 8.9.1 Monaghan Medical Company Information
  51. 8.9.2 Monaghan Medical Business Overview
  52. 8.9.3 Monaghan Medical Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Monaghan Medical Inhaler Devices for Respiratory Medicines Product Portfolio
  54. 8.9.5 Monaghan Medical Recent Developments
  55. 8.10 Koninklijke Philips
  56. 8.10.1 Koninklijke Philips Company Information
  57. 8.10.2 Koninklijke Philips Business Overview
  58. 8.10.3 Koninklijke Philips Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Koninklijke Philips Inhaler Devices for Respiratory Medicines Product Portfolio
  60. 8.10.5 Koninklijke Philips Recent Developments
  61. 8.11 H&T Presspart
  62. 8.11.1 H&T Presspart Company Information
  63. 8.11.2 H&T Presspart Business Overview
  64. 8.11.3 H&T Presspart Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 H&T Presspart Inhaler Devices for Respiratory Medicines Product Portfolio
  66. 8.11.5 H&T Presspart Recent Developments
  67. 8.12 GlaxoSmithKline (GSK)
  68. 8.12.1 GlaxoSmithKline (GSK) Company Information
  69. 8.12.2 GlaxoSmithKline (GSK) Business Overview
  70. 8.12.3 GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 GlaxoSmithKline (GSK) Inhaler Devices for Respiratory Medicines Product Portfolio
  72. 8.12.5 GlaxoSmithKline (GSK) Recent Developments
  73. 8.13 Chiesi Farmaceutici
  74. 8.13.1 Chiesi Farmaceutici Company Information
  75. 8.13.2 Chiesi Farmaceutici Business Overview
  76. 8.13.3 Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Chiesi Farmaceutici Inhaler Devices for Respiratory Medicines Product Portfolio
  78. 8.13.5 Chiesi Farmaceutici Recent Developments
  79. 8.14 Boehringer Ingelheim
  80. 8.14.1 Boehringer Ingelheim Company Information
  81. 8.14.2 Boehringer Ingelheim Business Overview
  82. 8.14.3 Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Boehringer Ingelheim Inhaler Devices for Respiratory Medicines Product Portfolio
  84. 8.14.5 Boehringer Ingelheim Recent Developments
  85. 8.15 AptarGroup
  86. 8.15.1 AptarGroup Company Information
  87. 8.15.2 AptarGroup Business Overview
  88. 8.15.3 AptarGroup Inhaler Devices for Respiratory Medicines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 AptarGroup Inhaler Devices for Respiratory Medicines Product Portfolio
  90. 8.15.5 AptarGroup Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Inhaler Devices for Respiratory Medicines Value Chain Analysis
  2. 9.1.1 Inhaler Devices for Respiratory Medicines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Inhaler Devices for Respiratory Medicines Sales Mode & Process
  6. 9.2 Inhaler Devices for Respiratory Medicines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Inhaler Devices for Respiratory Medicines Distributors
  9. 9.2.3 Inhaler Devices for Respiratory Medicines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst